K-tab Generic Name & Formulations
Potassium (as chloride) 10mEq; sust-rel tabs.
Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block.
K-tab Dosage and Administration
Do not chew or crush. Take with meals. Prophylaxis: 20mEq daily. Treatment: 40–100mEq daily in divided doses; max 20mEq/dose.
Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Esophageal compression due to enlarged left atrium. Decreased GI motility.
K-tab Boxed Warnings
Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.
Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets.
K-tab Adverse Reactions
Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Esophageal and GI ulceration, bleeding, obstruction, perforation.
K-tab Clinical Trials
K-tab Patient Counseling